HEALTH

IBTimes Logo

Bisphosphonate Osteoporosis Drugs: FDA Questions Long-term Effects

Biphosphonates, drugs introduced to the market 16 years ago that treats osteoporosis, need labeling to clarify how long patients should take them as data suggests that efficacy decreases while risk increases after some period, panels to the Food and Drug Administration (FDA) voted on Friday.
More news
Secretary Kathleen Sebelius

HHS Shells Out $700 Million For Community Health Centers Nationwide

The U.S. Department of Health and Human Services (HHS) on Thursday announced the availability of two funding opportunities for community health centers to help build, expand and improve community health centers across the U.S. to provide needed care to low-income Americans.
9/11 Reflections

9/11 - The Dust that Refuses to Settle

The dust that blanketed Ground Zero and much of lower Manhattan in the aftermath of the World Trade Center's collapse was full of toxic chemicals that left a deadly mark on thousands of rescue workers.
Prozac

Why Are Westerners So Depressed?

Two studies released over the last week report that up to half of Americans and 40 percent of Europeans will suffer from a mental health disorder during their lifetime.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.